CurveGen Inc. Business Introduction
We are building a collaborative network with powerful medical institutions and pharmaceutical companies both domestically and internationally to provide practical solutions!
CurveGen Inc. is a company that provides analytical AI in the life sciences field. We have a track record of delivering products and solutions born from important strategic projects by the Ministry of Health, Labour and Welfare, the Ministry of Economy, Trade and Industry, the Cabinet Office, and the Tokyo Metropolitan Government. We hold a portfolio of intellectual property with patent applications and acquisitions, establishing a technological advantage. 【Business Area】 ■ Analytical AI in the life sciences field *For more details, please download the PDF or feel free to contact us.
basic information
【Services】 ■ Cloud Sharing and Analysis CarbConnect ■ Accompanying Consulting *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Life Sciences DX/AI Solution Examples (Partial)】 ■ Bacterial species estimation using image AI ■ AI for classification support of blood cells in bone marrow smears ■ AI for quantitative evaluation and recovery period prediction using knee joint MRI images ■ AI for pregnancy and childbirth prediction (embryo time-lapse image analysis) ■ AI for determining chromosomal aneuploidy (embryo time-lapse image analysis) ■ AI for determining bacterial flora (Nugent Score AI) *For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Recommended products
Distributors
CarbGeM Inc. provides digital transformation (DX) and AI solutions specialized in the life sciences and healthcare sectors. Building on capabilities in medical data analysis, image-analysis AI, generative AI, and application development, we work together with academia, medical institutions, and companies to support the full journey from research and development through to real-world implementation. We have particular expertise in developing AI-based Software as a Medical Device (SaMD), navigating regulatory affairs, and establishing Quality Management Systems (QMS), backed by a proven track record of obtaining medical device approvals and notifications. We advance industry-academia partnerships around early-stage AI and data-science research emerging from academia, with technical implementation, clinical application, and commercialization firmly in view. We take the same approach with our corporate partners, pursuing co-creation to move research and new business initiatives forward while keeping technical implementation and regulatory requirements in mind. As a partner in joint research and new business development, we would welcome the opportunity to exchange ideas on areas where our expertise can add value—including data-collection design and the preparation of AI-ready data, DX/AI implementation, and the planning of regulatory and exit strategies. We would also be glad to take an active role in securing funding for joint projects.